
While we are proud of our history and expertise, keeping our position as a global thought leader requires the discipline to constantly push forward and innovate, with both services and technology. We are true pioneers in artificial intelligence in PV, and a trusted partner of global companies like Oracle and Deloitte.

To provide high added value pharmacovigilance that can reduce the potential harm from medicines. To create an exemplary culture that is appreciated and celebrated by the pharmacovigilance community, our employees, and our clients.

Our Local QPPVs and Local PV persons are already recruited and contracted, enabling us to deploy a complete local pharmacovigilance service within two months on average, during which we prepare all client-specific documentation and notify local regulatory agencies of the local QPPV or Local PV Person who will be in place.

Team has successful track record from leadership positions at Pfizer, BMS, Vertex, Sanofi, and senior ex-regulators from EMA, CHMP, PRAC, and representing EMA at ICH and CIOMS groups. Ex-member of EMA Innovation Taskforce finding the best new regulatory pathways for innovative products.

Team has successful track record from leadership positions at Pfizer, BMS, Vertex, Sanofi, and senior ex-regulators from EMA, CHMP, PRAC, and representing EMA at ICH and CIOMS groups. Ex-member of EMA Innovation Taskforce finding the best new regulatory pathways for innovative products.

Team has successful track record from leadership positions at Pfizer, BMS, Vertex, Sanofi, and senior ex-regulators from EMA, CHMP, PRAC, and representing EMA at ICH and CIOMS groups. Ex-member of EMA Innovation Taskforce finding the best new regulatory pathways for innovative products.

Team has successful track record from leadership positions at Pfizer, BMS, Vertex, Sanofi, and senior ex-regulators from EMA, CHMP, PRAC, and representing EMA at ICH and CIOMS groups. Ex-member of EMA Innovation Taskforce finding the best new regulatory pathways for innovative products.
Our Local QPPVs and Local PV persons are already recruited and contracted, enabling us to deploy a complete local pharmacovigilance service within two months on average, during which we prepare all client-specific documentation and notify local regulatory agencies of the local QPPV or Local PV Person who will be in place. While we are proud of our history and expertise, keeping our position as a global thought leader requires the discipline to constantly push forward and innovate, with both services and technology. We are true pioneers in artificial intelligence in PV, and a trusted partner of global companies like Oracle and Deloitte.



